NCT00470964

Brief Summary

Titanium Sapphire laser trabeculoplasty is effective in lowering intraocular pressure in glaucoma patients, and is comparable to argon laser trabeculoplasty

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 8, 2007

Completed
Last Updated

May 8, 2007

Status Verified

May 1, 2007

First QC Date

May 6, 2007

Last Update Submit

May 7, 2007

Conditions

Glaucoma, Open-Angle

Keywords

laser trabeculoplasty, glaucoma, argon, titanium-sapphireIOP lowering effectAdverse effectsIOP spikes

Outcome Measures

Primary Outcomes (1)

  • IOP

Interventions

Titanium Sapphire laser trabeculoplastyPROCEDURE

Eligibility Criteria

Age40 Years - 91 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Uncontrolled open angle glaucoma patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goldschleger Eye Institute

Ramat Gan, 52621, Israel

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleGlaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Shlomo Melamed, MD

    Goldschleger Eye Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Expanded Access
Yes

Study Record Dates

First Submitted

May 6, 2007

First Posted

May 8, 2007

Last Updated

May 8, 2007

Record last verified: 2007-05

Locations

IL(1)